Elos Medtech
+Subscribe to companyCoverage
- Addtech
- Alcadon
- Arise
- Avensia
- Bergs Timber
- BioGaia
- Biovica
- Boule Diagnostics
- Bredband2
- Brighter
- Briox
- Capacent
- Catella
- Catena
- Catena Media
- Cavotec
- Concordia Maritime
- Crown Energy
- CTT Systems
- Dedicare
- DistIT
- Diös
- Doro
- Elanders
- Elos Medtech
- Empir Group
- ENLABS
- Enzymatica
- Eolus Vind
- Eurocon
- eWork
- FastPartner
- Ferronordic
- Formpipe
- Fortnox
- Future Gaming Group
- G5 Entertainment
- GARO
- Generic
- Hifab
- Hoylu
- Intervacc
- INVISIO Communications
- ITAB Shop Concept
- JLT Mobile Computers
- Lagercrantz
- Lammhults
- Leading Edge Materials
- Magnolia Bostad
- MedicaNatumin
- Midsona
- Moment Group
- Motion Display
- NAXS
- Nilörngruppen
- Nolato
- Nordic Waterproofing
- Opus Group
- Poolia
- Pricer
- Proact
- Probi
- QuickCool
- Rottneros
- Seafire
- SinterCast
- SJR
- Stendörren
- Studsvik
- Swedencare
- Swedol
- Tethys Oil
- THQ Nordic
- VBG Group
- Vitec
- Vitrolife
- Zutec
Menu
Elos Medtech
- Addtech
- Alcadon
- Arise
- Avensia
- Bergs Timber
- BioGaia
- Biovica
- Boule Diagnostics
- Bredband2
- Brighter
- Briox
- Capacent
- Catella
- Catena
- Catena Media
- Cavotec
- Concordia Maritime
- Crown Energy
- CTT Systems
- Dedicare
- DistIT
- Diös
- Doro
- Elanders
- Elos Medtech
- Empir Group
- ENLABS
- Enzymatica
- Eolus Vind
- Eurocon
- eWork
- FastPartner
- Ferronordic
- Formpipe
- Fortnox
- Future Gaming Group
- G5 Entertainment
- GARO
- Generic
- Hifab
- Hoylu
- Intervacc
- INVISIO Communications
- ITAB Shop Concept
- JLT Mobile Computers
- Lagercrantz
- Lammhults
- Leading Edge Materials
- Magnolia Bostad
- MedicaNatumin
- Midsona
- Moment Group
- Motion Display
- NAXS
- Nilörngruppen
- Nolato
- Nordic Waterproofing
- Opus Group
- Poolia
- Pricer
- Proact
- Probi
- QuickCool
- Rottneros
- Seafire
- SinterCast
- SJR
- Stendörren
- Studsvik
- Swedencare
- Swedol
- Tethys Oil
- THQ Nordic
- VBG Group
- Vitec
- Vitrolife
- Zutec
Press the button and be introduced to a new random company!
Introduce me >UPCOMING EVENTS
We arrange several open investor events with our covered companies each year. Please subscribe to get information about our upcoming Introduce events.
Financials
Elos Medtech
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019e | 2019e | 2020e | 2020e | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 636 | 368 | 368 | 381 | 381 | 504 | 504 | 552 | 552 | 578 | 578 | 636 | 636 | 686 | 686 | 737 | 737 | ||
| Sales growth (%) | 10 | N/A | N/A | 3,5 | 3,5 | 32,2 | 32,2 | 9,6 | 9,6 | 4,7 | 4,7 | 10 | 10 | 7,9 | 7,9 | 7,4 | 7,4 | ||
| EBITDA | 92 | 68 | 68 | 68 | 68 | 79 | 79 | 97 | 97 | 94 | 94 | 92 | 92 | 119 | 119 | N/A | N/A | ||
| EBITDA margin (%) | 16,3 | 18,4 | 18,4 | 18,4 | 18,4 | 17,9 | 17,9 | 15,7 | 15,7 | 17,6 | 17,6 | 16,3 | 16,3 | 14,5 | 14,5 | 17,3 | 17,3 | ||
| EBIT adj | 43 | 27 | 27 | 27 | 27 | 37 | 37 | 39 | 39 | 43 | 43 | 43 | 43 | 46 | 46 | 66 | 66 | ||
| EBIT adj margin (%) | 7,4 | 7,4 | 7,4 | 7,4 | 7,4 | 9,7 | 9,7 | 7,7 | 7,7 | 7,7 | 7,7 | 7,4 | 7,4 | 7,2 | 7,2 | 9,6 | 9,6 | ||
| Pretax profit | 33 | 21 | 21 | 32 | 32 | 23 | 23 | 38 | 38 | 26 | 26 | 33 | 33 | 58 | 58 | 65 | 65 | ||
| EPS rep | 2,98 | 2,79 | 2,79 | 3,93 | 3,93 | 2,66 | 2,66 | 4,38 | 4,38 | 3,71 | 3,71 | 2,98 | 2,98 | 4,99 | 4,99 | 5,79 | 5,79 | ||
| EPS growth (%) | -19,7 | 0 | 0 | 40,8 | 40,8 | -32,4 | -32,4 | 64,6 | 64,6 | -15,2 | -15,2 | -19,7 | -19,7 | 67,5 | 67,5 | 16 | 16 | ||
| EPS adj | 3,67 | 2,79 | 2,79 | 4,5 | 4,5 | 4 | 4 | 4,38 | 4,38 | 3,71 | 3,71 | 3,67 | 3,67 | 4,99 | 4,99 | 5,79 | 5,79 | ||
| DPS | 0 | 2 | 2 | 3 | 3 | 1 | 1 | 1,3 | 1,3 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||
| EV/EBITDA (x) | 8,9 | 7,4 | 7,4 | 6,3 | 6,3 | 14 | 14 | 9,5 | 9,5 | 7,6 | 7,6 | 8,9 | 8,9 | 6,5 | 6,5 | 5,6 | 5,6 | ||
| EV/EBIT adj (x) | 17,9 | 18,4 | 18,4 | 11,7 | 11,7 | 28,7 | 28,7 | 21,7 | 21,7 | 16,8 | 16,8 | 17,9 | 17,9 | 11,7 | 11,7 | 9,7 | 9,7 | ||
| P/E (x) | 23 | 19,4 | 19,4 | 15,7 | 15,7 | 42,2 | 42,2 | 20,5 | 20,5 | 15,9 | 15,9 | 23 | 23 | 13,7 | 13,7 | 11,8 | 11,8 | ||
| P/E adj (x) | 18,6 | 19,4 | 19,4 | 13,8 | 13,8 | 28,1 | 28,1 | 20,5 | 20,5 | 15,9 | 15,9 | 18,6 | 18,6 | 13,7 | 13,7 | 11,8 | 11,8 | ||
| EV/sales (x) | 1,3 | 1,4 | 1,4 | 1,1 | 1,1 | 2,2 | 2,2 | 1,7 | 1,7 | 1,2 | 1,2 | 1,3 | 1,3 | 1,1 | 1,1 | 1 | 1 | ||
| FCF yield (%) | -0,6 | 20,4 | 20,4 | 8,4 | 8,4 | -21,3 | -21,3 | -20,8 | -20,8 | 2,5 | 2,5 | -0,6 | -0,6 | 7,3 | 7,3 | 8,8 | 8,8 | ||
| Dividend yield (%) | 0 | 3,7 | 3,7 | 4,9 | 4,9 | 0,9 | 0,9 | 1,5 | 1,5 | 0 | 0 | 0 | 0 | 1,5 | 1,5 | 1,5 | 1,5 | ||
| Net IB debt/EBITDA | 2,9 | 2,5 | 2,5 | 0,9 | 0,9 | 5,4 | 5,4 | 4 | 4 | 3,8 | 3,8 | 2,9 | 2,9 | 1,8 | 1,8 | 1,4 | 1,4 |
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019e | 2019e | 2020e | 2020e | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 636 | 368 | 368 | 381 | 381 | 504 | 504 | 552 | 552 | 578 | 578 | 636 | 636 | 686 | 686 | 737 | 737 | ||
| COGS | -459 | -273 | -273 | -273 | -273 | -368 | -368 | -395 | -395 | -415 | -415 | -459 | -459 | -486 | -486 | -520 | -520 | ||
| Gross profit | 176 | 95 | 95 | 108 | 108 | 136 | 136 | 157 | 157 | 163 | 163 | 176 | 176 | 201 | 201 | 217 | 217 | ||
| Other operating items | -84 | -28 | -28 | -40 | -40 | -57 | -57 | -60 | -60 | -68 | -68 | -84 | -84 | -82 | -82 | -88 | -88 | ||
| EBITDA | 92 | 68 | 68 | 68 | 68 | 79 | 79 | 97 | 97 | 94 | 94 | 92 | 92 | 119 | 119 | 129 | 129 | ||
| Depreciation on tangibles | -52 | -41 | -41 | -35 | -35 | -49 | -49 | -55 | -55 | -51 | -51 | -52 | -52 | -53 | -53 | -54 | -54 | ||
| Depreciation on intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EBITA | 40 | 27 | 27 | 34 | 34 | 31 | 31 | 43 | 43 | 43 | 43 | 40 | 40 | 66 | 66 | 75 | 75 | ||
| Goodwill impairment charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other impairment and amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EBIT | 40 | 27 | 27 | 34 | 34 | 31 | 31 | 43 | 43 | 43 | 43 | 40 | 40 | 66 | 66 | 75 | 75 | ||
| Other financial items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net financial items | -8 | -6 | -6 | -1 | -1 | -8 | -8 | -5 | -5 | -16 | -16 | -8 | -8 | -8 | -8 | -10 | -10 | ||
| Associated income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other EO items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Pretax profit | 33 | 21 | 21 | 32 | 32 | 23 | 23 | 38 | 38 | 26 | 26 | 33 | 33 | 58 | 58 | 65 | 65 | ||
| Tax | -9 | -5 | -5 | -8 | -8 | -6 | -6 | -11 | -11 | -4 | -4 | -9 | -9 | -17 | -17 | -18 | -18 | ||
| Net profit | 24 | 17 | 17 | 24 | 24 | 16 | 16 | 27 | 27 | 22 | 22 | 24 | 24 | 40 | 40 | 47 | 47 | ||
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net profit discontinued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net profit to shareholders | 24 | 17 | 17 | 24 | 24 | 16 | 16 | 27 | 27 | 22 | 22 | 24 | 24 | 40 | 40 | 47 | 47 | ||
| EPS | 2,98 | 2,79 | 2,79 | 3,93 | 3,93 | 2,66 | 2,66 | 4,38 | 4,38 | 3,71 | 3,71 | 2,98 | 2,98 | 4,99 | 4,99 | 5,79 | 5,79 | ||
| EPS Adj | 3,67 | 2,79 | 2,79 | 4,5 | 4,5 | 4 | 4 | 4,38 | 4,38 | 3,71 | 3,71 | 3,67 | 3,67 | 4,99 | 4,99 | 5,79 | 5,79 | ||
| Total extraordinary items after tax | -5,6 | 0 | 0 | -3,4 | -3,4 | -8,1 | -8,1 | 0 | 0 | 0 | 0 | -5,6 | -5,6 | 0 | 0 | 0 | 0 | ||
| Tax rate (%) | -26,5 | -21 | -21 | -26,1 | -26,1 | -28,4 | -28,4 | -30,1 | -30,1 | -14,5 | -14,5 | -26,5 | -26,5 | -30 | -30 | -28 | -28 | ||
| Gross margin (%) | 27,8 | 25,9 | 25,9 | 28,3 | 28,3 | 27 | 27 | 28,4 | 28,4 | 28,1 | 28,1 | 27,8 | 27,8 | 29,2 | 29,2 | 29,4 | 29,4 | ||
| EBITDA margin (%) | 14,5 | 18,4 | 18,4 | 17,9 | 17,9 | 15,7 | 15,7 | 17,6 | 17,6 | 16,3 | 16,3 | 14,5 | 14,5 | 17,3 | 17,3 | 17,5 | 17,5 | ||
| EBITA margin (%) | 6,3 | 7,4 | 7,4 | 8,8 | 8,8 | 6,1 | 6,1 | 7,7 | 7,7 | 7,4 | 7,4 | 6,3 | 6,3 | 9,6 | 9,6 | 10,2 | 10,2 | ||
| EBIT margin (%) | 6,3 | 7,4 | 7,4 | 8,8 | 8,8 | 6,1 | 6,1 | 7,7 | 7,7 | 7,4 | 7,4 | 6,3 | 6,3 | 9,6 | 9,6 | 10,2 | 10,2 | ||
| Pretax margin (%) | 5,1 | 5,8 | 5,8 | 8,5 | 8,5 | 4,5 | 4,5 | 6,9 | 6,9 | 4,5 | 4,5 | 5,1 | 5,1 | 8,4 | 8,4 | 8,8 | 8,8 | ||
| Net margin (%) | 3,8 | 4,6 | 4,6 | 6,2 | 6,2 | 3,2 | 3,2 | 4,8 | 4,8 | 3,9 | 3,9 | 3,8 | 3,8 | 5,9 | 5,9 | 6,3 | 6,3 | ||
| Growth rates Y/Y | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Sales growth (%) | 10 | N/A | N/A | 3,5 | 3,5 | 32,2 | 32,2 | 9,6 | 9,6 | 4,7 | 4,7 | 10 | 10 | 7,9 | 7,9 | 7,4 | 7,4 | ||
| EBITDA growth (%) | -2,1 | 0 | 0 | 0,6 | 0,6 | 16,3 | 16,3 | 22,7 | 22,7 | -3,3 | -3,3 | -2,1 | -2,1 | 28,6 | 28,6 | 8,8 | 8,8 | ||
| EBIT growth (%) | -5,7 | 0 | 0 | 23,2 | 23,2 | -9 | -9 | 40 | 40 | 0 | 0 | -5,7 | -5,7 | 63 | 63 | 14,5 | 14,5 | ||
| Net profit growth (%) | 7 | 0 | 0 | 40,8 | 40,8 | -32,4 | -32,4 | 64,6 | 64,6 | -15,2 | -15,2 | 7 | 7 | 67,5 | 67,5 | 16 | 16 | ||
| EPS growth (%) | -19,7 | 0 | 0 | 40,8 | 40,8 | -32,4 | -32,4 | 64,6 | 64,6 | -15,2 | -15,2 | -19,7 | -19,7 | 67,5 | 67,5 | 16 | 16 | ||
| Profitability | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| ROE (%) | 5,5 | 14,5 | 14,5 | 8,3 | 8,3 | 4,8 | 4,8 | 7,6 | 7,6 | 6,1 | 6,1 | 5,5 | 5,5 | 7,6 | 7,6 | 8,2 | 8,2 | ||
| ROE Adj (%) | 6,7 | 14,5 | 14,5 | 9,5 | 9,5 | 7,2 | 7,2 | 7,6 | 7,6 | 6,1 | 6,1 | 6,7 | 6,7 | 7,6 | 7,6 | 8,2 | 8,2 | ||
| ROCE (%) | 5,3 | 13,4 | 13,4 | 8,4 | 8,4 | 5,3 | 5,3 | 5,7 | 5,7 | 5,8 | 5,8 | 5,3 | 5,3 | 8,5 | 8,5 | 9,8 | 9,8 | ||
| ROCE Adj(%) | 6,1 | 13,4 | 13,4 | 9,2 | 9,2 | 6,7 | 6,7 | 5,7 | 5,7 | 5,8 | 5,8 | 6,1 | 6,1 | 8,5 | 8,5 | 9,8 | 9,8 | ||
| ROIC (%) | 3,5 | 9 | 9 | 5,3 | 5,3 | 3,4 | 3,4 | 3,6 | 3,6 | 4,4 | 4,4 | 3,5 | 3,5 | 5,2 | 5,2 | 6,2 | 6,2 | ||
| ROIC Adj (%) | 4 | 9 | 9 | 5,8 | 5,8 | 4,3 | 4,3 | 3,6 | 3,6 | 4,4 | 4,4 | 4 | 4 | 5,2 | 5,2 | 6,2 | 6,2 | ||
| Adj earnings numbers | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| EBITDA Adj | 98 | 68 | 68 | 72 | 72 | 87 | 87 | 97 | 97 | 94 | 94 | 98 | 98 | 119 | 119 | 129 | 129 | ||
| EBITDA Adj margin (%) | 15,4 | 18,4 | 18,4 | 18,8 | 18,8 | 17,4 | 17,4 | 17,6 | 17,6 | 16,3 | 16,3 | 15,4 | 15,4 | 17,3 | 17,3 | 17,5 | 17,5 | ||
| EBITA Adj | 46 | 27 | 27 | 37 | 37 | 39 | 39 | 43 | 43 | 43 | 43 | 46 | 46 | 66 | 66 | 75 | 75 | ||
| EBITA Adj margin (%) | 7,2 | 7,4 | 7,4 | 9,7 | 9,7 | 7,7 | 7,7 | 7,7 | 7,7 | 7,4 | 7,4 | 7,2 | 7,2 | 9,6 | 9,6 | 10,2 | 10,2 | ||
| EBIT Adj | 46 | 27 | 27 | 37 | 37 | 39 | 39 | 43 | 43 | 43 | 43 | 46 | 46 | 66 | 66 | 75 | 75 | ||
| EBIT Adj margin (%) | 7,2 | 7,4 | 7,4 | 9,7 | 9,7 | 7,7 | 7,7 | 7,7 | 7,7 | 7,4 | 7,4 | 7,2 | 7,2 | 9,6 | 9,6 | 10,2 | 10,2 | ||
| Pretax profit Adj | 38 | 21 | 21 | 36 | 36 | 31 | 31 | 38 | 38 | 26 | 26 | 38 | 38 | 58 | 58 | 65 | 65 | ||
| Net profit Adj | 30 | 17 | 17 | 27 | 27 | 24 | 24 | 27 | 27 | 22 | 22 | 30 | 30 | 40 | 40 | 47 | 47 | ||
| Net profit to shareholders Adj | 30 | 17 | 17 | 27 | 27 | 24 | 24 | 27 | 27 | 22 | 22 | 30 | 30 | 40 | 40 | 47 | 47 | ||
| Net Adj margin (%) | 4,7 | 4,6 | 4,6 | 7,1 | 7,1 | 4,8 | 4,8 | 4,8 | 4,8 | 3,9 | 3,9 | 4,7 | 4,7 | 5,9 | 5,9 | 6,3 | 6,3 |
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019e | 2019e | 2020e | 2020e | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventories | 165 | 116 | 116 | 113 | 113 | 130 | 130 | 131 | 131 | 142 | 142 | 165 | 165 | 175 | 175 | 184 | 184 | ||
| Receivables | 99 | 61 | 61 | 55 | 55 | 59 | 59 | 61 | 61 | 78 | 78 | 99 | 99 | 103 | 103 | 111 | 111 | ||
| Other current assets | 13 | 18 | 18 | 10 | 10 | 15 | 15 | 7 | 7 | 9 | 9 | 13 | 13 | 17 | 17 | 15 | 15 | ||
| Cash and liquid assets | 50 | 31 | 31 | 126 | 126 | 41 | 41 | 39 | 39 | 10 | 10 | 50 | 50 | 81 | 81 | 105 | 105 | ||
| Total assets | 981 | 530 | 530 | 608 | 608 | 882 | 882 | 888 | 888 | 848 | 848 | 981 | 981 | 1017 | 1017 | 1039 | 1039 | ||
| Shareholders equity | 511 | 233 | 233 | 339 | 339 | 331 | 331 | 367 | 367 | 369 | 369 | 511 | 511 | 551 | 551 | 590 | 590 | ||
| Minority | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total equity | 511 | 233 | 233 | 339 | 339 | 331 | 331 | 367 | 367 | 369 | 369 | 511 | 511 | 551 | 551 | 590 | 590 | ||
| Long-term debt | 283 | 204 | 204 | 150 | 150 | 441 | 441 | 395 | 395 | 339 | 339 | 283 | 283 | 263 | 263 | 243 | 243 | ||
| Pension debt | 37 | 0 | 0 | 33 | 33 | 26 | 26 | 28 | 28 | 29 | 29 | 37 | 37 | 37 | 37 | 37 | 37 | ||
| Convertible debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other long-term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Accounts payable | 32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32 | 32 | 33 | 33 | 35 | 35 | ||
| Other current liabilities | 119 | 94 | 94 | 86 | 86 | 83 | 83 | 98 | 98 | 110 | 110 | 119 | 119 | 133 | 133 | 134 | 134 | ||
| Total liabilities and equity | 888 | 0 | 0 | 0 | 0 | 530 | 530 | 608 | 608 | 882 | 882 | 888 | 888 | 848 | 848 | 981 | 981 | ||
| Net IB debt | 269 | 173 | 173 | 58 | 58 | 427 | 427 | 385 | 385 | 359 | 359 | 269 | 269 | 219 | 219 | 175 | 175 | ||
| Net IB debt excl. pension debt | 232 | 173 | 173 | 25 | 25 | 401 | 401 | 357 | 357 | 330 | 330 | 232 | 232 | 182 | 182 | 138 | 138 | ||
| Capital invested | 878 | 476 | 476 | 467 | 467 | 821 | 821 | 837 | 837 | 822 | 822 | 878 | 878 | 878 | 878 | 876 | 876 | ||
| Working capital | 232 | 177 | 177 | 168 | 168 | 189 | 189 | 193 | 193 | 220 | 220 | 232 | 232 | 245 | 245 | 260 | 260 | ||
| EV breakdown | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Market cap. diluted (m) | 552 | 327 | 327 | 374 | 374 | 679 | 679 | 542 | 542 | 358 | 358 | 552 | 552 | 552 | 552 | 552 | 552 | ||
| Net IB debt Adj | 269 | 173 | 173 | 58 | 58 | 427 | 427 | 385 | 385 | 359 | 359 | 269 | 269 | 219 | 219 | 175 | 175 | ||
| Market value of minority | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Reversal of shares and participations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Reversal of conv. debt assumed equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| EV | 821 | 500 | 500 | 432 | 432 | 1107 | 1107 | 927 | 927 | 716 | 716 | 821 | 821 | 770 | 770 | 726 | 726 | ||
| Capital efficiency (%) | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Total assets turnover (%) | 69,6 | 138,8 | 138,8 | 67 | 67 | 67,6 | 67,6 | 62,4 | 62,4 | 66,6 | 66,6 | 69,6 | 69,6 | 68,7 | 68,7 | 71,7 | 71,7 | ||
| Capital invested turnover (%) | 74,8 | 154,7 | 154,7 | 80,8 | 80,8 | 78,2 | 78,2 | 66,6 | 66,6 | 69,7 | 69,7 | 74,8 | 74,8 | 78,2 | 78,2 | 84,1 | 84,1 | ||
| Capital employed turnover (%) | 84,4 | 181,6 | 181,6 | 95 | 95 | 87,3 | 87,3 | 73,1 | 73,1 | 78,1 | 78,1 | 84,4 | 84,4 | 88,6 | 88,6 | 96,1 | 96,1 | ||
| Inventories / sales (%) | 24,2 | 15,7 | 15,7 | 30 | 30 | 24,1 | 24,1 | 23,7 | 23,7 | 23,7 | 23,7 | 24,2 | 24,2 | 24,8 | 24,8 | 24,4 | 24,4 | ||
| Customer advances / sales (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Payables / sales (%) | 2,5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,5 | 2,5 | 4,7 | 4,7 | 4,6 | 4,6 | ||
| Working capital / sales (%) | 35,6 | 24 | 24 | 45,3 | 45,3 | 35,4 | 35,4 | 34,6 | 34,6 | 35,7 | 35,7 | 35,6 | 35,6 | 34,7 | 34,7 | 34,2 | 34,2 | ||
| Financial risk and debt service | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Net debt / equity (%) | 52,6 | 74,1 | 74,1 | 17,1 | 17,1 | 129,3 | 129,3 | 104,9 | 104,9 | 97,2 | 97,2 | 52,6 | 52,6 | 39,7 | 39,7 | 29,6 | 29,6 | ||
| Net debt / market cap (%) | 48,2 | 56,7 | 56,7 | 14,9 | 14,9 | 72,7 | 72,7 | 69,2 | 69,2 | 73,5 | 73,5 | 48,2 | 48,2 | 39,6 | 39,6 | 31,6 | 31,6 | ||
| Equity ratio (%) | 52,1 | 43,9 | 43,9 | 55,7 | 55,7 | 37,5 | 37,5 | 41,3 | 41,3 | 43,5 | 43,5 | 52,1 | 52,1 | 54,2 | 54,2 | 56,8 | 56,8 | ||
| Net IB debt adj. / equity (%) | 52,6 | 74,1 | 74,1 | 17,1 | 17,1 | 129,3 | 129,3 | 104,9 | 104,9 | 97,2 | 97,2 | 52,6 | 52,6 | 39,7 | 39,7 | 29,6 | 29,6 | ||
| Current ratio (%) | 217,4 | 241,4 | 241,4 | 354,5 | 354,5 | 293,5 | 293,5 | 244,4 | 244,4 | 216 | 216 | 217,4 | 217,4 | 225,4 | 225,4 | 244,4 | 244,4 | ||
| EBITDA / net interest (%) | 1219,7 | 1169 | 1169 | 5246,2 | 5246,2 | 991,3 | 991,3 | 2027,1 | 2027,1 | 572,6 | 572,6 | 1219,7 | 1219,7 | 1465,9 | 1465,9 | 1255,8 | 1255,8 | ||
| Net IB debt / EBITDA (%) | 291,8 | 254,6 | 254,6 | 85 | 85 | 538,8 | 538,8 | 395,5 | 395,5 | 381,1 | 381,1 | 291,8 | 291,8 | 184,4 | 184,4 | 135,4 | 135,4 | ||
| Interest cover (%) | 532,8 | 469 | 469 | 2576,9 | 2576,9 | 381,3 | 381,3 | 889,6 | 889,6 | 259,8 | 259,8 | 532,8 | 532,8 | 811,7 | 811,7 | 731,9 | 731,9 | ||
| EBITDA | 92 | 68 | 68 | 68 | 68 | 79 | 79 | 97 | 97 | 94 | 94 | 92 | 92 | 119 | 119 | 129 | 129 | ||
| Net financial items | -8 | -6 | -6 | -1 | -1 | -8 | -8 | -5 | -5 | -16 | -16 | -8 | -8 | -8 | -8 | -10 | -10 | ||
| Paid tax | -9 | 0 | 0 | 0 | 0 | 0 | 0 | -11 | -11 | -4 | -4 | -9 | -9 | -17 | -17 | -18 | -18 | ||
| Non-cash items | 0 | 202 | 202 | -20 | -20 | 11 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash flow before change in WC | 76 | 264 | 264 | 46 | 46 | 83 | 83 | 81 | 81 | 74 | 74 | 76 | 76 | 93 | 93 | 101 | 101 | ||
| Change in WC | -12 | -177 | -177 | 9 | 9 | -21 | -21 | -4 | -4 | -27 | -27 | -12 | -12 | -12 | -12 | -15 | -15 | ||
| Operating cash flow | 64 | 87 | 87 | 55 | 55 | 62 | 62 | 77 | 77 | 47 | 47 | 64 | 64 | 81 | 81 | 86 | 86 | ||
| CAPEX tangible fixed assets | -67 | -21 | -21 | -24 | -24 | -46 | -46 | -35 | -35 | -38 | -38 | -67 | -67 | -41 | -41 | -37 | -37 | ||
| CAPEX intangible fixed assets | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Acquisitions and disposals | 0 | 0 | 0 | 0 | 0 | -160 | -160 | -160 | -160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Free cash flow | -3 | 67 | 67 | 32 | 32 | -145 | -145 | -112 | -112 | 9 | 9 | -3 | -3 | 40 | 40 | 49 | 49 | ||
| Dividend paid | 34 | -60 | -60 | -53 | -53 | 58 | 58 | -72 | -72 | -54 | -54 | 34 | 34 | -20 | -20 | -28 | -28 | ||
| Share issues and buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other non cash items | 59 | -180 | -180 | 136 | 136 | -282 | -282 | 227 | 227 | 71 | 71 | 59 | 59 | 30 | 30 | 23 | 23 | ||
| Decrease in net IB debt | 90 | -173 | -173 | 115 | 115 | -369 | -369 | 43 | 43 | 26 | 26 | 90 | 90 | 50 | 50 | 44 | 44 | ||
| Balance Sheet (SEKm) | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Goodwill | 235 | 0 | 0 | 48 | 48 | 45 | 45 | 235 | 235 | 254 | 254 | 235 | 235 | 235 | 235 | 235 | 235 | ||
| Indefinite intangible assets | 46 | 81 | 81 | 21 | 21 | 231 | 231 | 55 | 55 | 13 | 13 | 46 | 46 | 46 | 46 | 46 | 46 | ||
| Definite intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Tangible fixed assets | 364 | 218 | 218 | 230 | 230 | 357 | 357 | 354 | 354 | 335 | 335 | 364 | 364 | 352 | 352 | 335 | 335 | ||
| Other fixed assets | 9 | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 5 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | ||
| Fixed assets | 654 | 304 | 304 | 305 | 305 | 637 | 637 | 649 | 649 | 609 | 609 | 654 | 654 | 641 | 641 | 624 | 624 |
| SEKm | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019e | 2019e | 2020e | 2020e | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares outstanding adj. | 8 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 8 | 8 | 8 | 8 | 8 | 8 | ||
| Fully diluted shares Adj | 8 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 8 | 8 | 8 | 8 | 8 | 8 | ||
| EPS | 2,98 | 2,79 | 2,79 | 3,93 | 3,93 | 2,66 | 2,66 | 4,38 | 4,38 | 3,71 | 3,71 | 2,98 | 2,98 | 4,99 | 4,99 | 5,79 | 5,79 | ||
| Dividend per share Adj | 0 | 2 | 2 | 3 | 3 | 1 | 1 | 1,3 | 1,3 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||
| EPS Adj | 3,67 | 2,79 | 2,79 | 4,5 | 4,5 | 4 | 4 | 4,38 | 4,38 | 3,71 | 3,71 | 3,67 | 3,67 | 4,99 | 4,99 | 5,79 | 5,79 | ||
| BVPS | 63,33 | 38,48 | 38,48 | 55,97 | 55,97 | 54,63 | 54,63 | 60,62 | 60,62 | 60,98 | 60,98 | 63,33 | 63,33 | 68,32 | 68,32 | 73,11 | 73,11 | ||
| BVPS Adj | 34,19 | 38,48 | 38,48 | 48,07 | 48,07 | 47,17 | 47,17 | 21,8 | 21,8 | 19,03 | 19,03 | 34,19 | 34,19 | 39,18 | 39,18 | 43,98 | 43,98 | ||
| Net IB debt / share | 33,3 | 28,5 | 28,5 | 9,6 | 9,6 | 70,6 | 70,6 | 63,6 | 63,6 | 59,3 | 59,3 | 33,3 | 33,3 | 27,1 | 27,1 | 21,6 | 21,6 | ||
| Share price | 69,2 | 50,33 | 50,33 | 64,24 | 64,24 | 97,09 | 97,09 | 91,91 | 91,91 | 80,61 | 80,61 | 69,2 | 69,2 | 68,4 | 68,4 | 68,4 | 68,4 | ||
| Market cap. (m) | 558 | 304 | 304 | 389 | 389 | 587 | 587 | 556 | 556 | 488 | 488 | 558 | 558 | 552 | 552 | 552 | 552 | ||
| Valuation | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| P/E | 23 | 19,4 | 19,4 | 15,7 | 15,7 | 42,2 | 42,2 | 20,5 | 20,5 | 15,9 | 15,9 | 23 | 23 | 13,7 | 13,7 | 11,8 | 11,8 | ||
| EV/sales | 1,29 | 1,36 | 1,36 | 1,13 | 1,13 | 2,2 | 2,2 | 1,68 | 1,68 | 1,24 | 1,24 | 1,29 | 1,29 | 1,12 | 1,12 | 0,99 | 0,99 | ||
| EV/EBITDA | 8,9 | 7,4 | 7,4 | 6,3 | 6,3 | 14 | 14 | 9,5 | 9,5 | 7,6 | 7,6 | 8,9 | 8,9 | 6,5 | 6,5 | 5,6 | 5,6 | ||
| EV/EBITA | 20,4 | 18,4 | 18,4 | 12,9 | 12,9 | 36,3 | 36,3 | 21,7 | 21,7 | 16,8 | 16,8 | 20,4 | 20,4 | 11,7 | 11,7 | 9,7 | 9,7 | ||
| EV/EBIT | 20,4 | 18,4 | 18,4 | 12,9 | 12,9 | 36,3 | 36,3 | 21,7 | 21,7 | 16,8 | 16,8 | 20,4 | 20,4 | 11,7 | 11,7 | 9,7 | 9,7 | ||
| Dividend yield (%) | 0 | 3,7 | 3,7 | 4,9 | 4,9 | 0,9 | 0,9 | 1,5 | 1,5 | 0 | 0 | 0 | 0 | 1,5 | 1,5 | 1,5 | 1,5 | ||
| FCF yield (%) | -0,6 | 20,4 | 20,4 | 8,4 | 8,4 | -21,3 | -21,3 | -20,8 | -20,8 | 2,5 | 2,5 | -0,6 | -0,6 | 7,3 | 7,3 | 8,8 | 8,8 | ||
| P/BVPS | 1,08 | 1,41 | 1,41 | 1,1 | 1,1 | 2,06 | 2,06 | 1,48 | 1,48 | 0,97 | 0,97 | 1,08 | 1,08 | 1 | 1 | 0,94 | 0,94 | ||
| P/BVPS Adj | 2 | 1,41 | 1,41 | 1,29 | 1,29 | 2,38 | 2,38 | 4,11 | 4,11 | 3,11 | 3,11 | 2 | 2 | 1,75 | 1,75 | 1,56 | 1,56 | ||
| P/E Adj | 18,6 | 19,4 | 19,4 | 13,8 | 13,8 | 28,1 | 28,1 | 20,5 | 20,5 | 15,9 | 15,9 | 18,6 | 18,6 | 13,7 | 13,7 | 11,8 | 11,8 | ||
| EV/EBITDA Adj | 8,4 | 7,4 | 7,4 | 6 | 6 | 12,7 | 12,7 | 9,5 | 9,5 | 7,6 | 7,6 | 8,4 | 8,4 | 6,5 | 6,5 | 5,6 | 5,6 | ||
| EV/EBITA Adj | 17,9 | 18,4 | 18,4 | 11,7 | 11,7 | 28,7 | 28,7 | 21,7 | 21,7 | 16,8 | 16,8 | 17,9 | 17,9 | 11,7 | 11,7 | 9,7 | 9,7 | ||
| EV/EBIT Adj | 17,9 | 18,4 | 18,4 | 11,7 | 11,7 | 28,7 | 28,7 | 21,7 | 21,7 | 16,8 | 16,8 | 17,9 | 17,9 | 11,7 | 11,7 | 9,7 | 9,7 | ||
| EV/cap. employed | 1,1 | 1,2 | 1,2 | 1,1 | 1,1 | 1,5 | 1,5 | 1,2 | 1,2 | 1 | 1 | 1,1 | 1,1 | 1 | 1 | 1 | 1 | ||
| Investment ratios | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | |||
| Capex / sales | 10,6 | 5,5 | 5,5 | 6,2 | 6,2 | 9,2 | 9,2 | 5,3 | 5,3 | 6,5 | 6,5 | 10,6 | 10,6 | 5,9 | 5,9 | 5 | 5 | ||
| Capex / depreciation | 129,3 | 50,2 | 50,2 | 68,6 | 68,6 | 94,7 | 94,7 | 53,8 | 53,8 | 73,2 | 73,2 | 129,3 | 129,3 | 76,8 | 76,8 | 68,5 | 68,5 | ||
| Capex tangibles / tangible fixed assets | 18,4 | 9,8 | 9,8 | 10,4 | 10,4 | 13 | 13 | 9,8 | 9,8 | 11,2 | 11,2 | 18,4 | 18,4 | 11,6 | 11,6 | 11 | 11 | ||
| Capex intangibles / definite intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| Depreciation on intangibles / definite intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| Depreciation on tangibles / tangibles | 14,3 | 18,6 | 18,6 | 15,1 | 15,1 | 13,7 | 13,7 | 15,4 | 15,4 | 15,4 | 15,4 | 14,3 | 14,3 | 15 | 15 | 16,1 | 16,1 |
Key Figure Counter
It is not always easy to generate comparative valuations. Therefore, in order to make it easier for you as an investor, we have created this key figure calculator. Enter share price in the field below and then select the year in which you want to retrieve the financial data.
P/E
A common valuation multiple, the share price is divided by earnings per share.
P/E ratio stands for Price and Earnings. By dividing a company's market cap to its earnings, investors get a key ratio which they are able to compare between different companies. The ratio can either be calculated on historical or forward-looking numbers.
It is important to notice that earnings are calculated after taxes, which mean that they can vary between companies due to different accounting standards.
11,8
EV/EBIT
EV stands for Enterprise Value and is calculated as a company's markets cap in addition to its net debt. The net debt itself is computed through the company's interest-bearing debt minus total cash and cash equivalents.
EBIT is the Earnings Before Interest and Taxes which is the operating income. This result, in comparison to the P/E ratio, is not affected by any financial items.
9,6
EV/Sales
EV stands for Enterprise Value and is calculated as a company's market cap adjusted for its net debt. The net debt itself is computed through the company's interest-bearing debt minus total cash and cash equivalents. S is the company's total sales.
1,0
P/BVPS
P/B stands for Price to Book, which is used to compare a share's market cap to its book value. A P/B ratio that is below one is considered to be valued below its assets.
Companies with high return on equity are usually associated with high P/B ratios, and vice versa.
0,9
ROE
ROE stands for Return on Equity which is a measurement on shareholder's return on capital. It is a percentage based number, calculated as the amount of net income returned relative shareholder's equity.
7,9%
Yield
Profits can either be reinvested or returned to investors as dividends. Yield is measured as dividends in relation to the stock price.
1,5%
QUICK FACTS
- Jan Wahlström
- Yvonne Mårtensson
- Healthcare
- www.elosmedtech.com
- Small Cap
- 550,2 MSEK
- ELOS
- Q4 Report 18 Feb 2019
QUICK FACTS
- CEO
- Jan Wahlström
- Chairman
- Yvonne Mårtensson
- List
- Small Cap
- Sector
- Healthcare
QUICK FACTS
- Market Cap
- 550,2 MSEK
- Ticker
- ELOS
- Next Event
- 18 Feb 2019
- Website
- www.elosmedtech.com
Latest articles
-
Elos Medtech överlåter verksamhet inom segmentet Hearing Device & Vibration
9 Jan 2019 / Press release
-
Flaggningsmeddelande i Elos Medtech AB
19 Dec 2018 / Press release
-
Inbjudan till Introduce Investor Day 4 december
6 Nov 2018 / Article
-
Elos Medtech - Organic growth twice as good as expected
1 Nov 2018 / Analys
-
Elos Medtech Delårsrapport 1 januari - 30 september, 2018
25 Oct 2018 / Press release
